BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 21300519)

  • 1. Palliative gastrectomy and other factors affecting overall survival in stage IV gastric adenocarcinoma patients receiving chemotherapy: a retrospective analysis.
    Sougioultzis S; Syrios J; Xynos ID; Bovaretos N; Kosmas C; Sarantonis J; Dokou A; Tzivras D; Zografos G; Felekouras E; Papalambros E; Tsavaris N
    Eur J Surg Oncol; 2011 Apr; 37(4):312-8. PubMed ID: 21300519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P53 protein expression in gastric adenocarcinoma. Negative predictor of survival after postoperative adjuvant chemotherapy.
    Díez M; Medrano MJ; Gutierrez A; López A; Mugüerza JM; Hernández P; Lozano O; Noguerales F; Ruíz A; Granell J
    Anticancer Res; 2000; 20(5C):3929-33. PubMed ID: 11268479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
    Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
    Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No survival benefit from postoperative adjuvant chemotherapy after D2 radical resection for the patients with stage II gastric cancer.
    Chen S; Chen YB; Zhou ZW; Li W; Sun XW; Xu DZ; Li YF; Guan YX; Feng XY; Zhan YQ
    Am J Clin Oncol; 2011 Jun; 34(3):309-13. PubMed ID: 20838324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does graded histologic response after neoadjuvant chemotherapy predict survival for completely resected gastric cancer?
    Mansour JC; Tang L; Shah M; Bentrem D; Klimstra DS; Gonen M; Kelsen DP; Brennan MF; Coit DG
    Ann Surg Oncol; 2007 Dec; 14(12):3412-8. PubMed ID: 17909917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results following resection for stage IV gastric cancer; are better outcomes observed in selected patient subgroups?
    Lim S; Muhs BE; Marcus SG; Newman E; Berman RS; Hiotis SP
    J Surg Oncol; 2007 Feb; 95(2):118-22. PubMed ID: 17262741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palliative chemotherapy does not improve survival in metastatic esophageal cancer.
    Adenis A; Penel N; Horn S; Dominguez S; Vanhuyse M; Mirabel X
    Oncology; 2010; 79(1-2):46-54. PubMed ID: 21071989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of palliative gastrectomy in patients with incurable advanced gastric cancer.
    Kunisaki C; Makino H; Takagawa R; Oshima T; Nagano Y; Fujii S; Otsuka Y; Akiyama H; Ono HA; Kosaka T; Ichikawa Y; Shimada H
    Anticancer Res; 2008; 28(2B):1309-15. PubMed ID: 18505071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palliative gastrectomy in patients with stage IV gastric cancer--our recent experience.
    Lupaşcu C; Andronic D; Ursulescu C; Vasiluţă C; Raileanu G; Georgescu St; Niculescu D; Crumpei F; Târcoveanu E
    Chirurgia (Bucur); 2010; 105(4):473-6. PubMed ID: 20941968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does non-curative gastrectomy improve survival in patients with metastatic gastric cancer?
    Kokkola A; Louhimo J; Puolakkainen P
    J Surg Oncol; 2012 Aug; 106(2):193-6. PubMed ID: 22354864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Morbidity and mortality in gastric cancer surgery--analysis of 468 cases with gastric adenocarcinoma].
    Necula A; Vlad L; Iancu C; Munteanu D; Puia C; Bălă O; AlHajaar N; Pop F; Radu H; Osian G; Graur F; Furcea L; Stanca M; Molnar G; Mocanu L
    Chirurgia (Bucur); 2008; 103(5):529-37. PubMed ID: 19260628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact on survival of the number of lymph nodes removed in patients with node-negative gastric cancer submitted to extended lymph node dissection.
    Biffi R; Botteri E; Cenciarelli S; Luca F; Pozzi S; Valvo M; Sonzogni A; Chiappa A; Leal Ghezzi T; Rotmensz N; Bagnardi V; Andreoni B
    Eur J Surg Oncol; 2011 Apr; 37(4):305-11. PubMed ID: 21288685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic impact of resection margin involvement after extended (D2/D3) gastrectomy for advanced gastric cancer: a 15-year experience at a single institute.
    Cho BC; Jeung HC; Choi HJ; Rha SY; Hyung WJ; Cheong JH; Noh SH; Chung HC
    J Surg Oncol; 2007 May; 95(6):461-8. PubMed ID: 17192913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical profile of carcinoma stomach at a tertiary care hospital in south India.
    Sambasivaiah K; Ibrarullah M; Reddy MK; Reddy PV; Wagholikar G; Jaiman S; Reddy DG; Sarma KV; Hegde GN
    Trop Gastroenterol; 2004; 25(1):21-6. PubMed ID: 15303466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraoperative radiotherapy combined with adjuvant chemoradiotherapy for locally advanced gastric adenocarcinoma.
    Fu S; Lu JJ; Zhang Q; Yang Z; Peng L; Xiong F
    Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1488-94. PubMed ID: 18538489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perineural invasion after preoperative chemotherapy predicts poor survival in patients with locally advanced gastric cancer: gene expression analysis with pathologic validation.
    Jhawer M; Coit D; Brennan M; Qin LX; Gonen M; Klimstra D; Tang L; Kelsen DP; Shah MA
    Am J Clin Oncol; 2009 Aug; 32(4):356-62. PubMed ID: 19381079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of surgery in the patients with stage I and II primary gastric lymphoma.
    Takahashi I; Maehara Y; Koga T; Sumiyoshi Y; Oshiro T; Baba H; Kohnoe S; Okamura T; Uike N; Matsusaka T; Kume K; Sugimachi K
    Hepatogastroenterology; 2003; 50(51):877-82. PubMed ID: 12828109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical complications in gastric cancer patients preoperatively treated with chemotherapy: their risk factors and clinical relevance.
    An JY; Kim KM; Kim YM; Cheong JH; Hyung WJ; Noh SH
    Ann Surg Oncol; 2012 Aug; 19(8):2452-8. PubMed ID: 22395984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-operative chemotherapy in non-curative gastrectomy for advanced gastric cancer.
    Hanazaki K; Mochizuki Y; Machida T; Yokoyama S; Sodeyama H; Sode Y; Wakabayashi M; Kawamura N; Miyazaki T
    Hepatogastroenterology; 1999; 46(26):1238-43. PubMed ID: 10370699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing nodal ratio is a poor prognostic factor for survival in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant chemotherapy: a retrospective study.
    Kim JS; Kim MA; Oh DY; Lee SH; Kim DW; Im SA; Kim WH; Yang HK; Heo DS; Bang YJ; Lee KU; Kim TY; Kim TM; Kim NK; Choe KJ
    Jpn J Clin Oncol; 2011 Feb; 41(2):245-52. PubMed ID: 21106599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.